RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tanke Biosciences Stock

Tanke Biosciences Market capitalization 2024

Tanke Biosciences Market capitalization

173,213.04 USD

Ticker

TNBI

ISIN

US87583Y1073

In 2024, Tanke Biosciences's market cap stood at 173,213.04 USD, a -92.64% increase from the 2.35 M USD market cap in the previous year.

The Tanke Biosciences Market capitalization history

YEARMarket Capitalization (undefined USD)
2012173.21
2011-
2010-
2009-
2008-
2007-

Tanke Biosciences Aktienanalyse

What does Tanke Biosciences do?

Tanke Biosciences Corp is a biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune system disorders. The company was founded in 2016 and is headquartered in Beijing, China. Tanke Biosciences aims to provide patients worldwide access to high-quality medicines and improve the chances of recovery for people with serious illnesses. The business model of Tanke Biosciences is based on the discovery and development of new drugs that can be used in clinics and hospitals. The company's main focus is the research of protease inhibitors, molecules that inhibit the activity of enzymes and therefore reduce inflammation. The company has acquired world-leading expertise in the development of protease inhibitors and is one of the most promising companies in the industry in this area. Tanke Biosciences has various divisions in which the company operates. One of the most important divisions is the development of drugs for the treatment of autoimmune diseases. For this purpose, the company has developed a protease inhibitor that inhibits the activity of the protein DPP4. DPP4 is involved in the regulation of the immune system and plays an important role in the development of autoimmune diseases such as diabetes or rheumatoid arthritis. The DPP4 inhibitors of Tanke Biosciences are promising candidates for improved therapy of these diseases. Another division of Tanke Biosciences is the research of cancer therapies. For this purpose, the company has developed a protease inhibitor that inhibits the activity of the enzyme Cathepsin K. Cathepsin K is involved in the development and spread of malignant tumors and thus plays an important role in the fight against cancer. The Cathepsin K inhibitors of Tanke Biosciences are promising for the development of new cancer therapies. Tanke Biosciences also offers other products and services that serve the research of molecular drugs. These include, for example, peptide libraries that researchers can use to identify new drugs. In addition, the company offers comprehensive research services to support customers in drug discovery and development. Overall, Tanke Biosciences is an innovative biopharmaceutical company specializing in the discovery and development of new drugs for the treatment of autoimmune diseases, cancer, and other immune system disorders. With its products and services, the company makes an important contribution to improving the health of people worldwide. Tanke Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Tanke Biosciences's Market Capitalization

Tanke Biosciences's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Tanke Biosciences's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Tanke Biosciences's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Tanke Biosciences’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Tanke Biosciences stock

What is the current Tanke Biosciences market capitalization?

The current market capitalization of Tanke Biosciences is 173,213.04 USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Tanke Biosciences.

How has the market capitalization of Tanke Biosciences developed in recent years?

The market capitalization of Tanke Biosciences has increased/decreased by -92.64% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Tanke Biosciences?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Tanke Biosciences?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Tanke Biosciences have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Tanke Biosciences pay?

Over the past 12 months, Tanke Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tanke Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Tanke Biosciences?

The current dividend yield of Tanke Biosciences is .

When does Tanke Biosciences pay dividends?

Tanke Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tanke Biosciences?

Tanke Biosciences paid dividends every year for the past 0 years.

What is the dividend of Tanke Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tanke Biosciences located?

Tanke Biosciences is assigned to the '-' sector.

Wann musste ich die Aktien von Tanke Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tanke Biosciences from 9/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/21/2024.

When did Tanke Biosciences pay the last dividend?

The last dividend was paid out on 9/21/2024.

What was the dividend of Tanke Biosciences in the year 2023?

In the year 2023, Tanke Biosciences distributed 0 USD as dividends.

In which currency does Tanke Biosciences pay out the dividend?

The dividends of Tanke Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Tanke Biosciences

Our stock analysis for Tanke Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tanke Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.